Hepion Pharmaceuticals(CTRVP)
EDISON, NJ
PharmaceuticalFocus: Antiviral Therapies
Hepion Pharmaceuticals is a life sciences company focused on Antiviral Therapies.
Infectious DiseasesNeurology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
[14C]-rencofilstat 225mg
NASH With FibrosisClinical Trials (1)
NCT05737433Single Dose ADME Study of [14C]-Rencofilstat in Healthy Male Subjects
Phase 1CRV431
Hepatitis BClinical Trials (1)
NCT03596697A Study in Healthy Volunteers
Phase 1CRV431 75mg
NASH - Nonalcoholic SteatohepatitisClinical Trials (1)
NCT04480710A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects
Phase 2Rencofilstat
Nonalcoholic Steatohepatitis (NASH)Clinical Trials (1)
NCT05402371A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis
Phase 2rencofilstat, 75 mg
NASH With FibrosisClinical Trials (1)
NCT05461105A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2024
Portfolio: 5 clinical trials
Top TAs: Metabolic Diseases, Gastroenterology, Infectious Diseases
Publications: 14 in PubMed
SEC Filings: 2 available
Therapeutic Area Focus
Marketed
Pipeline